| Carol J Quinlan, | |
|
10 Tower Dr, Sun Prairie, WI 53590-1239 | |
| (608) 825-3690 | |
| (608) 825-3665 |
| Full Name | Carol J Quinlan |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 10 Tower Dr, Sun Prairie, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164609798 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 9882 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Carol J Quinlan, 1808 W Beltline Hwy, Madison, WI 53713-2334 Ph: (608) 250-1408 | Carol J Quinlan, 10 Tower Dr, Sun Prairie, WI 53590-1239 Ph: (608) 825-3690 |
News Archive
A nutrition education program in low-income child care centers can improve a child's at-home consumption of vegetables and low-fat/fat-free milk, according to a study by researchers from RTI International, Altarum Institute, and the U.S. Department of Agriculture. The study was supported by the USDA's Food and Nutrition Service.
Every day, every human on the planet is exposed to one of the most toxic substances we know. However, it's largely invisible and most people don't know whether they need to worry. In new book Particles in the Air, Doug Brugge aims to raise awareness of serious consequences for public health.
As the warm summer months approach, the New York City Department of Health and Mental Hygiene (DOHMH) reminds City landlords and residents to install window guards to help prevent deaths and injuries from window falls. DOHMH today cited data showing an overall decrease in the number of preventable falls since Section 131.15 of the City's Health Code
Onconova Therapeutics, Inc., a development-stage pharmaceutical company focused on discovering and developing novel small molecule drug products to treat cancer, today announced that tolerability and favorable anti-tumor activity data from a Phase 1 trial evaluating oral rigosertib, a dual pathway inhibitor, in patients with advanced solid tumors including refractory metastatic head and neck cancer were presented today at the American Association for Cancer Research Annual Meeting.
› Verified 6 days ago
Timothy Geschrey, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 660 S Grand Ave, Sun Prairie, WI 53590 Phone: 608-834-5601 | |
Jeffrey Zietlow, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2538 Ironwood Dr, Sun Prairie, WI 53590 Phone: 608-837-2867 | |
Ryan Dilley, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 302 S Grand Ave, Sun Prairie, WI 53590 Phone: 608-837-5949 | |
Renae E Pinter, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 660 S Grand Ave, Target Pharmacy T-2491, Sun Prairie, WI 53590 Phone: 608-834-5601 Fax: 608-834-5601 | |
Ms. Cheryl A Waterworth, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 275 Davison Dr, Sun Prairie, WI 53590 Phone: 608-837-8566 | |
Dr. Scott Proebstle, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 275 Davison Dr, Sun Prairie, WI 53590 Phone: 608-837-8566 | |
Jason Douglas Crawford, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 660 S Grand Ave, Sun Prairie, WI 53590 Phone: 608-834-5601 |